热门出版物 - 学术资源搜索

h5 指数:90
h5 中位数:119

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#4 Pulmonology
#14 Oncology

标题/作者	引用次数	年份
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification WD Travis, E Brambilla, AG Nicholson, Y Yatabe, JHM Austin, ... Journal of Thoracic Oncology 10 (9), 1243-1260	1652	2015
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer P Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ... Journal of Thoracic Oncology 11 (1), 39-51	1200	2016
PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project FR Hirsch, A McElhinny, D Stanforth, J Ranger-Moore, M Jansson, ... Journal of Thoracic Oncology 12 (2), 208-222	695	2017
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology NI Lindeman, PT Cagle, DL Aisner, ME Arcila, MB Beasley, EH Bernicker, ... Journal of Thoracic Oncology 13 (3), 323-358	468	2018
The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer R Rami-Porta, V Bolejack, J Crowley, D Ball, J Kim, G Lyons, T Rice, ... Journal of Thoracic Oncology 10 (7), 990-1003	397	2015
Checkpoint Inhibitors in Metastatic EGFR-Mutated Non–Small Cell Lung Cancer—A Meta-Analysis CK Lee, J Man, S Lord, M Links, V Gebski, T Mok, JCH Yang Journal of Thoracic Oncology 12 (2), 403-407	357	2017
Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation N Chen, W Fang, J Zhan, S Hong, Y Tang, S Kang, Y Zhang, X He, T Zhou, ... Journal of Thoracic Oncology 10 (6), 910-923	318	2015
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer WEE Eberhardt, A Mitchell, J Crowley, H Kondo, YT Kim, A Turrisi III, ... Journal of Thoracic Oncology 10 (11), 1515-1522	303	2015
The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics TYD Cheng, SM Cramb, PD Baade, DR Youlden, C Nwogu, ME Reid Journal of Thoracic Oncology 11 (10), 1653-1671	279	2016
The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer WD Travis, H Asamura, AA Bankier, MB Beasley, F Detterbeck, DB Flieder, ... Journal of Thoracic Oncology 11 (8), 1204-1223	261	2016
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer H Asamura, K Chansky, J Crowley, P Goldstraw, VW Rusch, ... Journal of Thoracic Oncology 10 (12), 1675-1684	261	2015
Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience LM Sholl, DL Aisner, M Varella-Garcia, LD Berry, D Dias-Santagata, ... Journal of Thoracic Oncology 10 (5), 768-777	225	2015
The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes A Marx, JKC Chan, JM Coindre, F Detterbeck, N Girard, NL Harris, ... Journal of Thoracic Oncology 10 (10), 1383-1395	216	2015
Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art? KM Kerr, MS Tsao, AG Nicholson, Y Yatabe, II Wistuba, FR Hirsch, ... Journal of Thoracic Oncology 10 (7), 985-989	214	2015
Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas K Kadota, J Nitadori, CS Sima, H Ujiie, NP Rizk, DR Jones, PS Adusumilli, ... Journal of Thoracic Oncology 10 (5), 806-814	211	2015
136O: Osimertinib combined with durvalumab in EGFR-mutant non-small cell lung cancer: Results from the TATTON phase Ib trial MJ Ahn, J Yang, H Yu, H Saka, S Ramalingam, K Goto, SW Kim, L Yang, ... Journal of Thoracic Oncology 11 (4), S115	207	2016
Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma ZY Dong, WZ Zhong, SY Liu, Z Xie, SP Wu, YL Wu JOURNAL OF THORACIC ONCOLOGY 12 (1), S432-S433	205	2017
PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project MS Tsao, KM Kerr, M Kockx, MB Beasley, AC Borczuk, J Botling, ... Journal of Thoracic Oncology 13 (9), 1302-1311	200	2018
First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases M Schuler, YL Wu, V Hirsh, K O’Byrne, N Yamamoto, T Mok, S Popat, ... Journal of Thoracic Oncology 11 (3), 380-390	197	2016
Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease P Hoffknecht, A Tufman, T Wehler, T Pelzer, R Wiewrodt, M Schütz, ... Journal of Thoracic Oncology 10 (1), 156-163	193	2015

1 - 20

计算机程序会自动估算并确定日期和引用次数。